Human medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Date of authorisation: 12/12/2024, Revision: 6, Status: Authorised

PSUSA/00002702/202509

PSUSA/00002904/202509

PSUSA/00010582/202509

Human medicines European public assessment report (EPAR): Omlyclo, omalizumab, Date of authorisation: 16/05/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Amglidia, glibenclamide, Date of authorisation: 24/05/2018, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Giotrif, afatinib, Date of authorisation: 25/09/2013, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Orencia, abatacept, Date of authorisation: 21/05/2007, Revision: 43, Status: Authorised

Human medicines European public assessment report (EPAR): Denbrayce, denosumab, Date of authorisation: 26/06/2025, Revision: 2, Status: Authorised

Agenda of the CAT meeting 11-13 May 2026